JP2001518892A5 - - Google Patents

Download PDF

Info

Publication number
JP2001518892A5
JP2001518892A5 JP1998542470A JP54247098A JP2001518892A5 JP 2001518892 A5 JP2001518892 A5 JP 2001518892A5 JP 1998542470 A JP1998542470 A JP 1998542470A JP 54247098 A JP54247098 A JP 54247098A JP 2001518892 A5 JP2001518892 A5 JP 2001518892A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998542470A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001518892A (ja
JP4401440B2 (ja
Filing date
Publication date
Priority claimed from FR9704398A external-priority patent/FR2761990B1/fr
Application filed filed Critical
Publication of JP2001518892A publication Critical patent/JP2001518892A/ja
Publication of JP2001518892A5 publication Critical patent/JP2001518892A5/ja
Application granted granted Critical
Publication of JP4401440B2 publication Critical patent/JP4401440B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP54247098A 1997-04-10 1998-04-10 ビンカアルカロイドの抗有糸分裂性ハロ誘導体 Expired - Lifetime JP4401440B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
FR97/04398 1997-04-10
PCT/FR1998/000730 WO1998045301A1 (fr) 1997-04-10 1998-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2004059502A Division JP4307292B2 (ja) 1997-04-10 2004-03-03 ビンカアルカロイドの抗有糸分裂性ハロ誘導体
JP2009058098A Division JP2009167196A (ja) 1997-04-10 2009-03-11 ビンカアルカロイドの抗有糸分裂性ハロ誘導体

Publications (3)

Publication Number Publication Date
JP2001518892A JP2001518892A (ja) 2001-10-16
JP2001518892A5 true JP2001518892A5 (https=) 2004-12-09
JP4401440B2 JP4401440B2 (ja) 2010-01-20

Family

ID=9505731

Family Applications (3)

Application Number Title Priority Date Filing Date
JP54247098A Expired - Lifetime JP4401440B2 (ja) 1997-04-10 1998-04-10 ビンカアルカロイドの抗有糸分裂性ハロ誘導体
JP2004059502A Expired - Lifetime JP4307292B2 (ja) 1997-04-10 2004-03-03 ビンカアルカロイドの抗有糸分裂性ハロ誘導体
JP2009058098A Pending JP2009167196A (ja) 1997-04-10 2009-03-11 ビンカアルカロイドの抗有糸分裂性ハロ誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2004059502A Expired - Lifetime JP4307292B2 (ja) 1997-04-10 2004-03-03 ビンカアルカロイドの抗有糸分裂性ハロ誘導体
JP2009058098A Pending JP2009167196A (ja) 1997-04-10 2009-03-11 ビンカアルカロイドの抗有糸分裂性ハロ誘導体

Country Status (15)

Country Link
US (1) US6127377A (https=)
EP (3) EP1357125A3 (https=)
JP (3) JP4401440B2 (https=)
AT (2) ATE270297T1 (https=)
AU (1) AU737549C (https=)
BR (2) BR9807944B1 (https=)
CA (3) CA2455416C (https=)
CY (2) CY1111476T1 (https=)
DE (3) DE69841766D1 (https=)
DK (2) DK1764368T3 (https=)
ES (2) ES2347878T3 (https=)
FR (2) FR2761990B1 (https=)
LU (1) LU91769I2 (https=)
PT (2) PT975640E (https=)
WO (1) WO1998045301A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
WO2005055939A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinca derivatives
WO2005055943A2 (en) * 2003-12-04 2005-06-23 Amr Technology, Inc. Vinorelbine derivatives
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
US7772177B2 (en) 2005-05-18 2010-08-10 Aegera Therapeutics, Inc. BIR domain binding compounds
FR2894966B1 (fr) 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
AU2007250443B2 (en) 2006-05-16 2013-06-13 Pharmascience Inc. IAP BIR domain binding compounds
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) * 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
WO2011098904A1 (en) 2010-02-12 2011-08-18 Aegera Therapeutics, Inc. Iap bir domain binding compounds
WO2011103007A2 (en) * 2010-02-22 2011-08-25 The Scripps Research Institute 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
WO2026064527A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Kras-targeting covalent-induced drug conjugates comprising a tubulin inhibitor payload
WO2026064520A1 (en) 2024-09-19 2026-03-26 Tesseract Medicines Us, Llc Covalent-induced drug conjugates targeting kras and comprising a tubulin inhibitor payload

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988B1 (fr) * 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Similar Documents

Publication Publication Date Title
JP2000509942A5 (https=)
JP2000509637A5 (https=)
JP2001513198A5 (https=)
JP2000509635A5 (https=)
JP2000510751A5 (https=)
JP2002512615A5 (https=)
JP2001510498A5 (https=)
JP2002503250A5 (https=)
JP2000509587A5 (https=)
JP2001516216A5 (https=)
JP2002513344A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508841A5 (https=)
JP2001525063A5 (https=)
JP2001524148A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510247A5 (https=)
JP2000510969A5 (https=)
JP2000508102A5 (https=)
JP2000508836A5 (https=)
JP2001518892A5 (https=)